IP Verse

Engmab Sàrl opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Aug 16, 2023

Title:

Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of Diseases

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3227333	Aug 16, 2023	Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of Diseases	3

J A KEMP LLP

PFIZER INC.

SCORPIO IP LIMITED

Feel free to send us a message here and we will get back to you